T. Rowe Price Associates’s Illumina ILMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$18.4M Buy
149,197
+15,280
+11% +$2.01M ﹤0.01% 1067
2025
Q4
$17.6M Buy
133,917
+4,360
+3% +$512K ﹤0.01% 1085
2025
Q3
$12.3M Buy
129,557
+8,699
+7% +$863K ﹤0.01% 1178
2025
Q2
$11.5M Buy
120,858
+4,482
+4% +$364K ﹤0.01% 1084
2025
Q1
$9.23M Buy
116,376
+8,028
+7% +$869K ﹤0.01% 1128
2024
Q4
$14.5M Sell
108,348
-3,720
-3% -$530K ﹤0.01% 1059
2024
Q3
$14.6M Sell
112,068
-584
-0.5% -$72K ﹤0.01% 1062
2024
Q2
$11.8M Sell
112,652
-111,695
-50% -$12.5M ﹤0.01% 1082
2024
Q1
$30M Sell
224,347
-196,475
-47% -$26.3M ﹤0.01% 864
2023
Q4
$57M Sell
420,822
-40,679
-9% -$4.69M 0.01% 669
2023
Q3
$61.6M Sell
461,501
-327,846
-42% -$53.9M 0.01% 622
2023
Q2
$144M Sell
789,347
-150,046
-16% -$30.4M 0.02% 457
2023
Q1
$213M Sell
939,393
-1,233,007
-57% -$252M 0.03% 368
2022
Q4
$427M Buy
2,172,400
+1,582,283
+268% +$328M 0.07% 258
2022
Q3
$110M Buy
590,117
+64,318
+12% +$12.7M 0.02% 470
2022
Q2
$94.3M Sell
525,799
-28,296
-5% -$7.23M 0.01% 680
2022
Q1
$188M Buy
554,095
+270,277
+95% +$91.3M 0.02% 545
2021
Q4
$105M Buy
283,818
+6,375
+2% +$2.42M 0.01% 750
2021
Q3
$109M Buy
277,443
+10,867
+4% +$5M 0.01% 736
2021
Q2
$123M Sell
266,576
-179,371
-40% -$72.2M 0.01% 714
2021
Q1
$167M Buy
445,947
+155,950
+54% +$63.6M 0.02% 605
2020
Q4
$104M Sell
289,997
-11,312
-4% -$3.61M 0.01% 710
2020
Q3
$90.6M Sell
301,309
-13,921
-4% -$4.8M 0.01% 685
2020
Q2
$114M Sell
315,230
-25,443
-7% -$8.19M 0.01% 602
2020
Q1
$90.5M Sell
340,673
-192,341
-36% -$53.8M 0.01% 598
2019
Q4
$172M Sell
533,014
-55,309
-9% -$16.8M 0.02% 512
2019
Q3
$174M Sell
588,323
-120,661
-17% -$35.6M 0.02% 486
2019
Q2
$254M Sell
708,984
-400,313
-36% -$126M 0.04% 410
2019
Q1
$335M Sell
1,109,297
-289,380
-21% -$84.4M 0.05% 333
2018
Q4
$408M Buy
1,398,677
+311,002
+29% +$96.3M 0.07% 272
2018
Q3
$388M Sell
1,087,675
-800,403
-42% -$256M 0.06% 324
2018
Q2
$513M Sell
1,888,078
-299,773
-14% -$76.3M 0.08% 247
2018
Q1
$503M Sell
2,187,851
-1,010,794
-32% -$232M 0.08% 254
2017
Q4
$680M Sell
3,198,645
-457,751
-13% -$94.2M 0.11% 202
2017
Q3
$709M Buy
3,656,396
+324,756
+10% +$60.5M 0.12% 184
2017
Q2
$562M Sell
3,331,640
-3,174,454
-49% -$549M 0.1% 222
2017
Q1
$1.08B Sell
6,506,094
-441,943
-6% -$69.6M 0.2% 121
2016
Q4
$865M Buy
6,948,037
+2,185,749
+46% +$295M 0.17% 142
2016
Q3
$842M Buy
4,762,288
+144,342
+3% +$23.1M 0.17% 143
2016
Q2
$631M Buy
4,617,946
+1,043,573
+29% +$148M 0.13% 180
2016
Q1
$564M Sell
3,574,373
-84,535
-2% -$12.9M 0.12% 200
2015
Q4
$683M Buy
3,658,908
+1,888,624
+107% +$305M 0.14% 166
2015
Q3
$303M Sell
1,770,284
-359,929
-17% -$72.8M 0.07% 309
2015
Q2
$452M Sell
2,130,213
-127,202
-6% -$24.8M 0.09% 242
2015
Q1
$408M Buy
2,257,415
+26,322
+1% +$4.96M 0.08% 272
2014
Q4
$401M Sell
2,231,093
-131,960
-6% -$23.3M 0.09% 275
2014
Q3
$377M Sell
2,363,053
-224,823
-9% -$37.6M 0.08% 279
2014
Q2
$449M Sell
2,587,876
-169,647
-6% -$25.3M 0.1% 243
2014
Q1
$399M Sell
2,757,523
-1,239,024
-31% -$182M 0.09% 264
2013
Q4
$430M Sell
3,996,547
-68,983
-2% -$6.32M 0.1% 249
2013
Q3
$320M Buy
4,065,530
+2,302
+0.1% +$176K 0.08% 291
2013
Q2
$296M Buy
+4,063,228
New +$260M 0.08% 299

Other funds holding ILMN

T. Rowe Price Associates's ILMN Position: Q1 2026 in Review

T. Rowe Price Associates increased its Illumina (ILMN) stake by 11% in Q1 2026, buying an estimated $2.01M and bringing the position to 149,197 shares worth $18.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1067.

T. Rowe Price Associates first reported a position in ILMN in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.08B in Q1 2017. 844 funds tracked by Wall St. Rank hold ILMN as of Q1 2026.

  • T. Rowe Price Associates held 149,197 shares of Illumina worth $18.4M as of Q1 2026.
  • T. Rowe Price Associates bought 15,280 Illumina shares in Q1 2026, an estimated $2.01M.
  • Illumina made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #1067 holding.
  • T. Rowe Price Associates first reported a position in Illumina in Q2 2013 and has held it in 52 quarters since.
  • T. Rowe Price Associates's Illumina position peaked at $1.08B in Q1 2017.
  • 844 funds tracked by Wall St. Rank held Illumina as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.